2020
DOI: 10.1002/btpr.2947
|View full text |Cite
|
Sign up to set email alerts
|

Application of Raman spectroscopy in monoclonal antibody producing continuous systems for downstream process intensification

Abstract: Monoclonal antibodies (mAbs) are biopharmaceuticals produced by mammalian cell lines in bioreactors at a variety of scales. Cell engineering, media optimization, process monitoring, and control strategies for in vitro production have become crucial subjects to meet increasing demand for these high value pharmaceuticals. Raman Spectroscopy has gained great attention in the pharmaceutical industry for process monitoring and control to maintain quality assurance. For the first time, this article demonstrated the … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
26
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 36 publications
(26 citation statements)
references
References 38 publications
0
26
0
Order By: Relevance
“…C—N), 1190 cm −1 (tryptophan, phenylalanine, str. C—N and bending N—H of Amide III), 1318 cm −1 (α-helix, Amide III), and 1448 cm −1 (Amide II/N—H bending, C—N stretch, bending CH 2 of proteins) [34] , [35] , [36] , [37] , [38] , [39] .
Fig.
…”
Section: Resultsmentioning
confidence: 99%
“…C—N), 1190 cm −1 (tryptophan, phenylalanine, str. C—N and bending N—H of Amide III), 1318 cm −1 (α-helix, Amide III), and 1448 cm −1 (Amide II/N—H bending, C—N stretch, bending CH 2 of proteins) [34] , [35] , [36] , [37] , [38] , [39] .
Fig.
…”
Section: Resultsmentioning
confidence: 99%
“…C–N in protein, phenylalanine), 1189 cm −1 (tryptophan, phenylalanine, str. C–N and bending N–H of Amide III), 1318 cm −1 (α-helix, Amide III), and 1444 cm −1 (Amide II/N–H bending, C–N stretch, bending CH 2 of proteins) [ 23 28 ].
Fig.
…”
Section: Resultsmentioning
confidence: 99%
“…This is presumably because these tools are fairly new and significant characterization work still remains to be done to understand or establish their full potential. Unlike other more well-established PAT like Raman probes widely used for bio-process monitoring 29 31 , applications of flow cytometry have been limited to clinical use. Arguably, the long standing history of routine utilization of flow cytometers in rigorous clinical settings 32 to identify and monitor disease and respond to treatment provides evidence of robustness of these platforms.…”
Section: Discussionmentioning
confidence: 99%